Developing iPSC-Derived Products for Alzheimer’s & Parkinson’s Disease
Time: 12:30 pm
day: Conference Day One
Details:
- Integrating novel differentiation protocols to produce high-quality iPSC-derived cell types Optimizing manufacturing processes for scalable and consistent production of therapeutic products
- Addressing regulatory requirements to expedite the development and approval of iPSCbased therapies
